Nasopharyngeal carcinoma in dermatomyositis patients: A 10-year retrospective review in Hospital Selayang, Malaysia

Reports of Practical Oncology and Radiotherapy

Volumn 19, Issue 5, 2012, Pages 332-336

  Teoh, J W ^a,b   Yunus, Razif M ^a   Hassan, Faridah ^b   Ghazali, Norazmi ^b   Abidin, Zainal A Z ^b  

^a UNIVERSITI KEBANGSAAN MALAYSIA MEDICAL CENTER   (Malaysia)

^b Selayang Hospital   (Malaysia)

Author keywords

Dermatomyositis; Epstein Barr viral capsid IgA; Nasopharyngeal carcinoma; Paraneoplastic; WHO histology

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CLINICAL ARTICLE; DERMATOMYOSITIS; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; EARLY DIAGNOSIS; EPSTEIN BARR VIRUS; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; HYPEREMIA; MALAYSIA; MALE; NASAL BIOPSY; NASOPHARYNX CARCINOMA; RETROSPECTIVE STUDY;

EID: 84955709759     PISSN: 15071367     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rpor.2014.02.005     Document Type: Article

References (15)

1. Callen J.P. Dermatomyositis. Lancet 2000, 355:53-57.
2. Toro C., Rinaldo A., Silver C.E., Politi M., Ferlito A. Paraneoplastic syndromes in patients with nasopharyngeal cancer. Auris Nasus Larynx 2009, 36:513-520.
3. Tang M.M., Thevarajah S. Paraneoplastic dermatomyositis: a 12-year retrospective review in the department of dermatology Hospital Kuala Lumpur. Med J Malays 2010, 65:138-142.
4. Zhang W., Jiang S.P., Huang L. Dermatomyositis and malignancy. Eur Rev Med Pharmacol Sci 2009, 13:77-80.
5. Chen Y.J., Wu C.Y., Huang Y.L., Wang C.B., Shen J.L., Chang Y.T. Cancer risks of dermatomyositis and polymyositis: a nationwide cohort study in Taiwan. Arthritis Res Ther 2010, 12:R70.
6. Stockton D., Doherty V.R., Brewster D.H. Risk of cancer in patients with dermatomyositis or polymyositis, and follow up implications: a Scottish population-based cohort study. Br J Cancer 2001, 85:41-45.
7. Chan H.L. Dermatomyositis and cancer in Singapore. Int J Dermatol 1985, 27:447-450.
8. Peng J.C., Sheen T.S., Hsu M.M. Nasopharyngeal carcinoma with dermatomyositis: analysis of 12 cases. Arch Otolaryngol Head Neck Surg 1995, 121:1298-1301.
9. Tanimoto K., Nakano K., Kano S., et al. Classification criteria for polymyositis and dermatomyositis. J Rheumatol 1995, 22:668-674.
10. Stertz G. Polymyositis. Berl Klin Wochenschr 1916, 53:489.
11. Liu W.C., Ho M., Koh W.P., et al. An 11-year review of dermatomyositis in Asian patients. Ann Acad Med Singap 2010, 39:843-847.
12. Hill C.L., Zhang Y., Sigurgeirsson B., et al. Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet 2001, 357:96-100.
13. Mebazaa A., Boussen H., Nouira R., et al. Dermatomyositis and malignancy in Tunisia: a multicenter national retrospective study of 20 cases. J Am Acad Dermatol 2003, 48:530-534.
14. Chow W.H., Gridley G., Mellemkjaer L., Mclaughlin J.K., Olsen J.H., Fraumeni J.F. Cancer risk following polymyositis and dermatomyositis: a nationwide cohort study in Denmark. Cancer Causes Control 1995, 6:9-13.
15. Gulley M.L., Amin M.B., Nicholls J.M., et al. Epstein-Barr virus is detected in undifferentiated nasopharyngeal carcinoma but not in lymphoepithelioma-like carcinoma of the urinary bladder. Hum Pathol 1995, 26:1207-1214.